MADISON, WI, JUNE 5, 2018 Imbed Biosciences, a developer of advanced biomaterials for soft tissue repair and regeneration, today announced the launch of a Microlyte® Matrix clinical research program which will comprise multiple sites, studies and a nationwide patient registry. The first study, underway at… Read More »Imbed Biosciences Launches Microlyte Matrix Clinical Research Program
Madison, WI, June 5, 2018– Imbed Biosciences, a developer of advanced biomaterials for soft tissue repair and regeneration, today announced the launch of a MicroLyte® Ag Antimicrobial Matrix clinical research program which will comprise multiple sites, studies and a nationwide patient registry. The first study,… Read More »Imbed Biosciences Launches MicroLyte® Ag Antimicrobial Matrix Clinical Research Program
Madison, WI, May 31, 2018 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, announced today that its flagship product, MicroLyte® Ag Matrix,is now available to physicians and other clinicians at Rush University Medical Center in Chicago, IL. MicroLyte® Ag Matrix is the first… Read More »MicroLyte® Ag Matrix Added to Formulary at Rush Medical Center
Madison, WI, April 3, 2018– Today Imbed Biosciences, Inc. announced that the Japan Patent Office has granted 14 claims of the company’s Japanese Patent Application No. 2015-541849, titled “Methods and Compositions for Wound Healing.” The granted claims provide comprehensive coverage to Imbed’s nanometer-thick polymer multilayer… Read More »Imbed Biosciences’ Key Patent Claims Granted in Japan
Madison, WI, November 7, 2017 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, is pleased to share that two of its team members—Jeffrey Dalsin, Ph.D. and Robert Beckman—have been named to the 2017 edition of Madison Magazine’s prestigious M-List. This year, the… Read More »Imbed Biosciences’ Team Members Honored in List of Health Innovators
Madison, WI, April 4, 2017 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, announced today that the company will present new data and information featuring its MicroLyte™ antimicrobial and antibiofilm wound dressings at the Spring Symposium on Advanced Wound Care (SAWC) in… Read More »Imbed Biosciences Advanced Wound Care Portfolio Highlighted SAWC Spring 2017
Madison, WI, October 1, 2016 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, announced today that Jeffrey Dalsin, Ph.D. will join the Imbed leadership team as Vice President of Product Development. Dr. Dalsin will lead development of Imbed’s flagship product Microlyte®… Read More »Imbed Bio Recruits Jeffrey Dalsin To Lead Product Development
Madison, WI, September 9, 2016 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, announced today that the company has received certification from British Standards Institution (BSI) Group America, Inc. that the company complies with the requirements of ISO 13485:2003 for an… Read More »Imbed Biosciences Secures ISO 13485:2003 Certification
MADISON, WI (Aug 5, 2016) – Imbed Biosciences announced today that it has received clearance from the Food and Drug Administration (FDA) to market its patented Microfilm™ wound dressing—Microlyte® Ag, for human use. The dressing is an ultrathin hydrogel sheet as thin as human hair… Read More »Imbed Receives FDA Clearance for Bacteria-Killing Wound Dressing
Imbed Bio Wins 2016 Wound Care Innovation Award in Bremen, Germany Bremen, Germany (May 12, 2016) – Imbed Biosciences announces that its microfilm wound dressing technology has today won the annual 2016 Wound Care Innovation Award at the European Wound Management Association (EWMA) conference… Read More »Imbed Bio Wins 2016 Wound Care Innovation Award in Bremen, Germany